77
EXHIBIT 3.1
-----------
This is an Exhibit to the Form 20-F of Sinovac Biotech Ltd.
-----------------------------------------------------------
Attached find the following materials:
Articles of Amendment dated October 21, 2003
--------------------------------------------
End of Exhibit 3.1
---------
(SEAL)
FINANCIAL SERVICES REGULATORY COMMISSION
ANTIGUA AND BARBUDA
CERTIFICATE
OF AMENDMENT OF ARTICLES
Pursuant to Section 161 (1)(a) of the International
Business Corporations Act, Cap. 222, the undersigned
hereby certifies that:
NET-FORCE SYSTEMS INC.
----------------------
By Special Resolution of the company dated October 8th, 2003
changed its name to:
SINOVAC BIOTECH LTD.
--------------------
/s/ (illegible)
----------------------------------------
for Administrator
Financial Services Regulatory Commission
REGISTERED
(SEAL)
Registered at St. John's Antigua,
this 21st of October, 2003
INTERNATIONAL BUSINESS CORPORATIONS ACT, CAP.222
FORM 3
ARTICLES OF AMENDMENT
(Section 164)
NET-FORCE SYSTEMS INC. 011949
.................................................................................
1. Name of Corporation 2. Corporation No.
.................................................................................
3. The articles of the above-named corporation are amended as follows:
ARTICLE I
---------
The name of the company is changed from NET-FORCE SYSTEMS INC. to SINOVAC
BIOTECH LTD.
ARTICLE V
---------
CORPORATE PURPOSE
-----------------
The existing Article is amended by deleting it in its entirety and by replacing
it with the new "Corporate Purpose" clause detailed in the attachment hereto:
Oct. 20, 2003 /s/ Lily Wang SECRETARY
.................................................................................
Date Signature Description of Office
.................................................................................
For Ministry use only
.................................................................................
File
..........................
ARTICLE V
---------
CORPORATE PURPOSE
-----------------
The objects for which the Company is established are:
a) To conduct any and all business activities permitted by the laws of the
State of Antigua and Barbuda as an International Business Corporation.
b) To acquire and deal with any property, real or personal, to erect any
buildings, and generally to do all acts and things which, in the opinion of the
Company or the Directors, may be conveniently, or profitably, or usefully,
acquired and dealt with, carried on, erected or done by the Company in
connection with said property.
c) To generally have and exercise all powers, rights and privileges necessary
and incident to carrying out properly the objects herein mentioned.
The Company shall not engage in International banking, Trust, Insurance, Betting
and Bookmaking or any other activity which requires a License under the
International Business Corporation Act.
The company shall be primarily engaged in research, development and
commercialization of human vaccines for infectious diseases.